Updated Results from Single-Agent Phase 1 Clinical Trial of RTX-240 in Advanced Solid Tumors to…
HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company…
OSLO, Norway, March 08, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD),…
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST),…
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company…
Clinical Update from Phase 1/2 study of IO102-IO103 in Combination with Nivolumab in Metastatic Melanoma…
Updated data from Phase 1 expansion cohort of ZN-c3 in uterine serous carcinoma (USC) will…
ORIC-533 oral presentation and poster presentation to highlight potential of small molecule inhibitor of CD73…
– Abstract highlights the Company’s progress in applying gene circuits to improve the cytotoxicity and…
FORT COLLINS, Colo., March 08, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
– Clinical Data from Cohort A of the Ongoing Phase 1/2 Trial of CFT7455, a…
Oral presentation to showcase NGM Bio’s in vitro and in vivo research demonstrating potential advantages…
— Recorded Third Quarter Revenue of $31.5 Million — — Myford South and Viral Vector…
SEATTLE, March 08, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…
BOULDER, Colo., March 08, 2022 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell” or the “Company”)…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:…
Pioneer of IVL Selected as the Second Most Innovative Medical Device Company SANTA CLARA, Calif.,…
BOSTON, March 08, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. announced today the publication of…
Toronto, Ontario–(Newsfile Corp. – March 8, 2022) – Xigem Technologies Corporation (“Xigem” or the “Company“)…